Share chart Roche Holding AG
Extended chart
Simple chart
About Roche Holding AG
Roche Holding AG занимается фармацевтическим и диагностическим бизнесом в Швейцарии, Германии, США, Австрии, Нидерландах, Великобритании, Франции, Бельгии и других странах. Компания предлагает фармацевтические продукты для лечения онкологии, неврологии, инфекционных заболеваний, иммунологии, сердечно-сосудистой и метаболической, офтальмологической и респираторной, а также анемии, рака, дерматологии, гемофилии, воспалительных и аутоиммунных, неврологических и трансплантационных заболеваний. more detailsMain settings
ISIN
CH0012032048
Industry
Pharmaceuticals
Sector
Health Care
Валюта
usd
Валюта отчета
chf
Див.доход ао
3.35
Дивиденд ао
11.02
Сайт
Grade
Underestimation
| Title | Value | Grade |
| P/S | 3.29 | 5 |
| P/BV | 5.68 | 2 |
| P/E | 24.79 | 6 |
Efficiency
| Title | Value | Grade |
| ROA | 8.61 | 3 |
| ROE | 27.1 | 8 |
| ROIC | 0 | 0 |
Dividends
| Title | Value | Grade |
| Dividend yield | 3.35 | 8.38 |
| DSI | 1 | 10 |
| Average dividend growth | 4.43 | 7.38 |
Debt
| Title | Value | Grade |
| Debt/EBITDA | 1.48 | 8 |
| Debt/Ratio | 0.3404 | 10 |
| Debt/Equity | 1.82 | 7 |
Growth impulse
| Title | Value | Grade |
| Yield Revenue, % | 6.98 | 1 |
| Yield Ebitda, % | 10.38 | 2 |
| Yield EPS, % | -41.24 | 0 |
Dividends
Prices
| Price | Min. | Max. | Change | Changes in the industry | Changes in the index | |
| Yesterday | 333.18 $ | 0 $ | 0 $ | 0.69 % | 0 % | 0 % |
| Week | 327.72 $ | 328.52 $ | 335.49 $ | 2.37 % | 0 % | 0 % |
| Month | 313.21 $ | 311.7 $ | 335.49 $ | 7.11 % | 0 % | 0 % |
| Three month | 295.55 $ | 286.95 $ | 350.66 $ | 13.51 % | 0 % | 0 % |
| Half a year | 320.64 $ | 273.1 $ | 351.5 $ | 4.63 % | 0 % | 0 % |
| Year | 336 $ | 267.8 $ | 351.5 $ | -0.15 % | 0 % | 0 % |
| 3 years | 311.08 $ | 233.27 $ | 351.5 $ | 7.85 % | 0 % | 0 % |
| 5 years | 342.05 $ | 233.27 $ | 425.14 $ | -1.92 % | 0 % | 0 % |
| 10 years | 0 $ | 210.46 $ | 425.14 $ | 0 % | 0 % | 0 % |
| Year to date | 326.74 $ | 273.1 $ | 351.5 $ | 2.68 % | 0 % | 0 % |
Main owners
Contained in ETF
ETF | Share, % | Profitability for 1 year, % | Commission, % |
FinEx Ex-USA ETF USD
|
1.77 | 45.15 | 0.9 |
| 1.77 | 45.15 | 0.9 |
|---|
Similar companies
P/E & P/BV
Company management
| Head | Job title | Payment | Year of birth |
| Dr. Severin Schwan Ph.D. | Executive Chairman | 8.31M | 1967 (58 years) |
| Dr. Alan Hippe | Chief Financial & Information Officer | 4.54M | 1967 (58 years) |
| Ms. Cristina A. Wilbur | Chief People Officer | 3.23M | 1967 (58 years) |
| Dr. Thomas Schinecker | Chief Executive Officer | 4.28M | 1975 (50 years) |
| Dr. Bruno Eschli | Head of Investor Relations | N/A | |
| Ms. Claudia Bockstiegel | General Counsel | N/A | 1964 (61 year) |
| Ms. Pascale Schmidt | Chief Compliance Officer | N/A | 1973 (52 years) |
| Ms. Barbara Schadler | Head of Group Communications | N/A | 1962 (63 years) |
| Dr. Nicolas Dunant | Head of Group Media Relations | N/A | |
| Mr. Boris L. Zaitra | Head of Corporate Business Development | N/A | 1972 (53 years) |
About company
Address: Switzerland, Basel, Grenzacherstrasse 124 - Open in google maps, Open in yandex maps
Website: https://www.roche.com
Website: https://www.roche.com
